BioLife Solutions, Inc.
BLFS
$35.07
-$0.16-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 948.30% | -236.12% | -3,028.04% | 88.07% | 89.82% |
| Total Depreciation and Amortization | -43.85% | -43.37% | -62.26% | 76.44% | 59.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -225.47% | 1,449.80% | 1,994.02% | -15.28% | -54.32% |
| Change in Net Operating Assets | -212.36% | -136.98% | -121.76% | -487.01% | -678.54% |
| Cash from Operations | -23.04% | -11.29% | 80.28% | 85.16% | 18,602.38% |
| Capital Expenditure | -4.38% | -107.10% | -89.43% | -43.24% | 16.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -145.24% | -187.44% | -189.01% | 14.12% | -9.75% |
| Cash from Investing | -278.69% | -251.00% | -224.66% | 108.44% | 165.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 32.68% | 13.19% | -17.54% | -294.44% | -2,206.42% |
| Issuance of Common Stock | 49.61% | 87.39% | -83.78% | -99.20% | -98.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -492.86% | -210.00% | -595.29% | -974.87% | 103.01% |
| Cash from Financing | -27.73% | -51.09% | -24.25% | -275.17% | -225.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -14.71% | 212.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -216.28% | -228.10% | -209.94% | 8.68% | 1,505.37% |